Usefulness of positron emission tomography for differentiating gliomas according to the 2016 World Health Organization classification of tumors of the central nervous system

被引:24
|
作者
Takei, Hiroaki [1 ,2 ,4 ]
Shinoda, Jun [1 ,2 ,3 ]
Ikuta, Soko [5 ]
Maruyama, Takashi [5 ]
Muragaki, Yoshihiro [5 ]
Kawasaki, Tomohiro [1 ,2 ,4 ]
Ikegame, Yuka [1 ,2 ,3 ]
Okada, Makoto [1 ,2 ]
Ito, Takeshi [1 ,2 ]
Asano, Yoshitaka [1 ,2 ,3 ]
Yokoyama, Kazutoshi [1 ,2 ]
Nakayama, Noriyuki [4 ]
Yano, Hirohito [4 ]
Iwama, Toru [4 ]
机构
[1] Kizawa Mem Hosp, Dept Neurosurg, Minokamo, Gifu, Japan
[2] Kizawa Mem Hosp, Chubu Med Ctr Prolonged Traumat Brain Dysfunct, Minokamo, Gifu, Japan
[3] Gifu Univ, Grad Sch Med, Dept Clin Brain Sci, Gifu, Japan
[4] Gifu Univ, Grad Sch Med, Dept Neurosurg, Gifu, Japan
[5] Tokyo Womens Med Univ, Dept Neurosurg, Tokyo, Japan
基金
日本学术振兴会;
关键词
C-11-methionine; C-11-choline; F-18-fluorodeoxyglucose; positron emission tomography; glioma; isocitrate dehydrogenase mutation; oncology; C-11-METHIONINE PET; C-11; METHIONINE; IDH2; MUTATIONS; BRAIN-TUMORS; F-18-FDG PET; SURVIVAL; C-11-CHOLINE; DIAGNOSIS; NECROSIS; CHOLINE;
D O I
10.3171/2019.5.JNS19780
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
OBJECTIVE: Positron emission tomography (PET) is important in the noninvasive diagnostic imaging of gliomas. There are many PET studies on glioma diagnosis based on the 2007 WHO classification; however, there are no studies on glioma diagnosis using the new classification (the 2016 WHO classification). Here, the authors investigated the relationship between uptake of 11C-methionine (MET), 11C-choline (CHO), and 18F-fluorodeoxyglucose (FDG) on PET imaging and isocitrate dehydrogenase (IDH) status (wild-type [IDH-wt] or mutant [IDH-mut]) in astrocytic and oligodendroglial tumors according to the 2016 WHO classification. METHODS: In total, 105 patients with newly diagnosed cerebral gliomas (6 diffuse astrocytomas [DAs] with IDH-wt, 6 DAs with IDH-mut, 7 anaplastic astrocytomas [AAs] with IDH-wt, 24 AAs with IDH-mut, 26 glioblastomas [GBMs] with IDH-wt, 5 GBMs with IDH-mut, 19 oligodendrogliomas [ODs], and 12 anaplastic oligodendrogliomas [AOs]) were included. All OD and AO patients had both IDH-mut and 1p/19q codeletion. The maximum standardized uptake value (SUV) of the tumor/mean SUV of normal cortex (T/N) ratios for MET, CHO, and FDG were calculated, and the mean T/N ratios of DA, AA, and GBM with IDH-wt and IDH-mut were compared. The diagnostic accuracy for distinguishing gliomas with IDH-wt from those with IDH-mut was assessed using receiver operating characteristic (ROC) curve analysis of the mean T/N ratios for the 3 PET tracers. RESULTS: There were significant differences in the mean T/N ratios for all 3 PET tracers between the IDH-wt and IDH-mut groups of all histological classifications (p < 0.001). Among the 27 gliomas with mean T/N ratios higher than the cutoff values for all 3 PET tracers, 23 (85.2%) were classified into the IDH-wt group using ROC analysis. In DA, there were no significant differences in the T/N ratios for MET, CHO, and FDG between the IDH-wt and IDH-mut groups. In AA, the mean T/N ratios of all 3 PET tracers in the IDH-wt group were significantly higher than those in the IDH-mut group (p < 0.01). In GBM, the mean T/N ratio in the IDH-wt group was significantly higher than that in the IDH-mut group for both MET (p = 0.034) and CHO (p = 0.01). However, there was no significant difference in the ratio for FDG. CONCLUSIONS: PET imaging using MET, CHO, and FDG was suggested to be informative for preoperatively differentiating gliomas according to the 2016 WHO classification, particularly for differentiating IDH-wt and IDH-mut tumors.
引用
收藏
页码:1010 / 1019
页数:10
相关论文
共 50 条
  • [21] Major Changes in 2021 World Health Organization Classification of Central Nervous System Tumors
    Kurokawa, Ryo
    Kurokawa, Mariko
    Baba, Akira
    Ota, Yoshiaki
    Pinarbasi, Emile
    Camelo-Piragua, Sandra
    Capizzano, Aristides A.
    Liao, Eric
    Srinivasan, Ashok
    Moritani, Toshio
    RADIOGRAPHICS, 2022, 42 (05) : 1474 - 1493
  • [22] World Health Organization 2021 Classification of Central Nervous System Tumors and Implications for Therapy for Adult-Type Gliomas A Review
    Berger, Tamar R.
    Wen, Patrick Y.
    Lang-Orsini, Melanie
    Chukwueke, Ugonma N.
    JAMA ONCOLOGY, 2022, 8 (10) : 1493 - 1501
  • [23] Upstaging and Downstaging in Gliomas-Clinical Implications for the Fifth Edition of the World Health Organization Classification of Tumors of the Central Nervous System
    Trifanescu, Oana Gabriela
    Trifanescu, Raluca Alexandra
    Mitrica, Radu
    Mitrea, Dan
    Ciornei, Ana
    Georgescu, Mihai
    Butnariu, Ioana
    Gales, Laurentia Nicoleta
    Serbanescu, Luiza
    Anghel, Rodica Maricela
    Paun, Mihai-Andrei
    DIAGNOSTICS, 2023, 13 (02)
  • [24] Positron emission tomography and the central nervous system
    Robinson, RO
    Ferrie, CD
    Capra, M
    Maisey, MN
    ARCHIVES OF DISEASE IN CHILDHOOD, 1999, 81 (03) : 263 - 270
  • [25] Changes to pediatric brain tumors in 2021 World Health Organization classification of tumors of the central nervous system
    Murat Alp Oztek
    Sakura M. Noda
    Erin K. Romberg
    Bonnie L. Cole
    Jason N. Wright
    Gisele E. Ishak
    Francisco A. Perez
    Pediatric Radiology, 2023, 53 : 523 - 543
  • [26] Changes to pediatric brain tumors in 2021 World Health Organization classification of tumors of the central nervous system
    Oztek, Murat Alp
    Noda, Sakura M.
    Romberg, Erin K.
    Cole, Bonnie L.
    Wright, Jason N.
    Ishak, Gisele E.
    Perez, Francisco A.
    PEDIATRIC RADIOLOGY, 2023, 53 (03) : 523 - 543
  • [27] Impact of the 2016 World Health Organization Classification of Tumours of the Central Nervous System: an Irish experience
    Fearon, Conor
    Loftus, Teresa
    Byrne, Amber Lynn
    Heffernan, Josephine
    Cooney, Maeve
    Heeney, Ciara
    Walsh, Andrea
    Lorigan, Jennifer
    Beausang, Alan
    Cryan, Jane
    Farrell, Michael
    Brett, Francesca
    IRISH JOURNAL OF MEDICAL SCIENCE, 2020, 189 (03) : 799 - 803
  • [28] Impact of the 2016 World Health Organization Classification of Tumours of the Central Nervous System: an Irish experience
    Conor Fearon
    Teresa Loftus
    Amber Lynn Byrne
    Josephine Heffernan
    Maeve Cooney
    Ciara Heeney
    Andrea Walsh
    Jennifer Lorigan
    Alan Beausang
    Jane Cryan
    Michael Farrell
    Francesca Brett
    Irish Journal of Medical Science (1971 -), 2020, 189 : 799 - 803
  • [29] Clinical Laboratory Testing Practices in Diffuse Gliomas Prior to Publication of 2021 World Health Organization Classification of Central Nervous System Tumors
    Ramkissoon, Shakti H.
    Fernandes, Helen
    Lopez-Terrada, Dolores H.
    Hameed, Meera R.
    Trembath, Dimitri G.
    Bridge, Julia A.
    Lindeman, Neal I.
    Souers, Rhona J.
    Vasalos, Patricia
    Brat, Daniel J.
    Moncur, Joel T.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2023, 147 (05) : 518 - 524
  • [30] Pathological Classification of the Intramedullary Spinal Cord Tumors According to 2021 World Health Organization Classification of Central Nervous System Tumors, a Single-Institute Experience
    Park, Sung-Hye
    Won, Jae Kyung
    Kim, Chi Heon
    Phi, Ji Hoon
    Kim, Seung-Ki
    Choi, Seung Hong
    Chung, Chun Kee
    NEUROSPINE, 2022, 19 (03) : 780 - 791